pindolol has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Neuroectodermal Tumors, Primitive, Peripheral: A group of highly cellular primitive round cell neoplasms which occur extracranially in soft tissue and bone and are derived from embryonal neural crest cells. These tumors occur primarily in children and adolescents and share a number of characteristics with EWING SARCOMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fishman, PH | 1 |
| Nussbaum, E | 1 |
| Duman, RS | 1 |
1 other study available for pindolol and Neuroectodermal Tumors, Primitive, Peripheral
| Article | Year |
|---|---|
Characterization and regulation of beta 1-adrenergic receptors in a human neuroepithelioma cell line.
Topics: Adrenergic beta-Antagonists; Binding, Competitive; Cell Membrane; Cyclic AMP; DNA Probes; Down-Regul | 1991 |